RUSH System for CAR-T Cells
Scale or prepare manufacturing, process control, GMP readiness and quality workflows.
Offer overview
What this offer helps you achieve
Scale or prepare manufacturing, process control, GMP readiness and quality workflows.
Scientific and technical scope
Our CAR-T cell technology, CARTuneTM, addresses the high toxicity in CAR-T therapies while maintening their efficiency. Based on our proprietary "traffic switch" platform and the RUSH system, it controls CAR protein expression using Biotin, a non-toxic molecule. This innovation enhances efficacy and reduces toxicity, making it suitable for both Leukemia and solid tumors, and allowing for versatile, off-the-shelf treatment options.
Capabilities mobilised
Therapeutic areasFormulation and synthesisValidation using preclinical modelsBioproductionPlatforms
Application fields
Oncology
Discuss this offer
Could this capability strengthen your R&D programme?
Present your scientific, technical or clinical need and identify the most relevant route to collaboration.
Continue exploring
Related expertise for your programme
Offers selected through shared capabilities, application fields or institute expertise.
